title: [Ciprofloxacin and pivampicillin in acute epididymitis in men above the age of 40 years].
abstract: Ciprofloxacin 500 mg orally twice daily was compared to pivampicillin 700 mg orally twice daily for 10 days in 172 men (41-85 years) with acute epididymitis. Failure of treatment occurred in 48 patients, in 15/76 (19.7%) receiving ciprofloxacin versus in 33/82 (40.2%) receiving pivampicillin (p = 0.006). Ciprofloxacin 500 mg orally twice daily is more effective than pivampicillin 700 mg orally twice daily and has fewer adverse events.
authors.affiliation: Kirurgisk afdeling D, Amtssygehuset i Glostrup.
authors.forename: J H
authors.initials: JH
authors.lastname: Eickhoff
authors.forename: N
authors.initials: N
authors.lastname: Frimodt-Møller
authors.forename: S
authors.initials: S
authors.lastname: Walter
authors.forename: C
authors.initials: C
authors.lastname: Frimodt-Møller
mesh_terms: D000208:Acute Disease; D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002939:Ciprofloxacin / Q000008:administration & dosage / Q000627:therapeutic use*; D004311:Double-Blind Method; D004823:Epididymitis / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D010406:Penicillins / Q000008:administration & dosage / Q000627:therapeutic use*; D010917:Pivampicillin / Q000008:administration & dosage / Q000627:therapeutic use*; D011446:Prospective Studies; D012008:Recurrence; D016896:Treatment Outcome
chemical_list: D000890:Anti-Infective Agents; D010406:Penicillins; D010917:Pivampicillin; D002939:Ciprofloxacin